Searle & Co’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,900
| Closed | -$36.1K | – | 178 |
|
|
2024
Q3 | $36.1K | Sell |
13,900
-1,100
| -7% | -$2.86K | 0.01% | 169 |
|
|
2024
Q2 | $44.4K | Buy |
15,000
+1,100
| +8% | +$3.26K | 0.01% | 180 |
|
|
2024
Q1 | $63K | Hold |
13,900
| – | – | 0.02% | 160 |
|
|
2023
Q4 | $79.4K | Hold |
13,900
| – | – | 0.02% | 156 |
|
|
2023
Q3 | $63.9K | Hold |
13,900
| – | – | 0.02% | 142 |
|
|
2023
Q2 | $107K | Hold |
13,900
| – | – | 0.03% | 150 |
|
|
2023
Q1 | $94.2K | Hold |
13,900
| – | – | 0.03% | 146 |
|
|
2022
Q4 | $141K | Hold |
13,900
| – | – | 0.05% | 144 |
|
|
2022
Q3 | $137K | Hold |
13,900
| – | – | 0.05% | 140 |
|
|
2022
Q2 | $148K | Hold |
13,900
| – | – | 0.06% | 144 |
|
|
2022
Q1 | $136K | Hold |
13,900
| – | – | 0.05% | 151 |
|
|
2021
Q4 | $199K | Buy |
+13,900
| New | +$199K | 0.07% | 154 |
|